ArticleAngewandte Chemie (International ed. in English)2022

Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance.

Tian Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.